Hypo Hub - Wednesday 14 November 2018

09:00 - 10:00

Registration

10:10 - 10:45

Keynote – An update from NHS England Diabetes

This session will look back at the last 12 months and go through the various strands of work being done in prevention of Type 2 diabetes; treatment & care - as well as work on going in the digital sphere. This session will also give audience the chance to ask the NHSE team any queries they may have about the future too.

National Clinical Director for Obesity and Diabetes, NHS England
Diabetes Consultant & National Associate Clinical Director Diabetes, NHS England
10:50 - 11:20

A guide to managing hypoglycaemia in hospital – updated JBDS Guidelines

A presentation of real inpatient case scenarios where hypoglycaemia events have occurred. Delegates will be encouraged to think about what caused the event, whether anything could have been done to prevent it and consider whether the episode was treated correctly. The session will include signposting to national treatment guidelines and will include considering frequency of…


Esther Walden
Lead DISN NNUH Chair, DISN UK Group
11:20 - 12:15

NETWORKING & EXHIBITION

12:15 - 12:45

Hypoglycaemia in adults in the community – recognition, management & prevention

This presentation will explore the recognition, treatment and prevention of hypoglycaemia as seen in the community setting as a practical and interactive session. It will provide signposting to practical information for people with diabetes, their families and carers as well as healthcare professionals to support education relating to hypoglycaemia. Learning outcomes: List the signs and…


Nurse Consultant – Diabetes, Barnet Enfield & Haringey MHT, Co-Chair TREND-UK and Chair, ITM
12:50 - 13:20

Clinical outcomes of ultra-long acting insulin analogues: impact on hypoglycaemia

This session will assess the comparative data on hypoglycaemic profiles of the two current ultra long-acting basal analogue insulins available outlining the differences, benefits and place in therapy. Learning outcomes: Attendees will be able to see the benefits of both Insulins and place in therapies Attendees will be helped in the design of local pathways…


Dr Pratik Choudhary
Clinical lead for T1 Diabetes, Islet & Pancreas transplantation, Consultant in Diabetes, King's College Hospital
This promotional session has been organised by Sanofi and the speaker remunerated by Sanofi
13:20 - 14:35

NETWORKING & EXHIBITION

14:40 - 15:10

Hypo research at JDRF

Hypoglycaemia, or hypos, can be frightening and dangerous experiences for people living with type 1 diabetes, particularly when coupled with an impaired awareness of hypoglycaemia. This session will cover JDRF’s strategic approach for research into hypos, and a few projects currently active in the UK. Learning outcomes: Understand JDRF’s strategy regarding hypo research Understand how…


Senior Research Communications & Engagement Officer, JDRF
15:15 - 15:45

Making the most of the AGP in clinic

More and more people living with Type 1 diabetes in the UK have access to the FreeStyle Libre system. This brings a number of challenges to the Type 1 diabetes clinic consultation. Many health care professionals report feeling ‘out of my depth’ or ‘overwhelmed’ by the available glucose data. In response to this, in this…


Consultant Diabetologist, Derby Teaching Hospitals NHS Foundation Trust
15:45 - 16:40

NETWORKING & EXHIBITION

16:40 - 17:10

Measuring variations in Hypos – GIRFT

Discussion of GIRFT process around hypos in hospital and highlighting areas of good practice. Learning outcomes: Review variation of hypos Learn from process of targeting variation Contribute to process


Diabetes Consultant & National Associate Clinical Director Diabetes, NHS England
Novo Nordisk Banner

Our site is intended for UK Healthcare Professionals

Are you a UK Healthcare Professional?

We’re sending you to our partner charity’s site. 

DRWF provide information and support for people with diabetes and their friends & families